3/30
06:18 am
bjdx
Bluejay Diagnostics (BJDX) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
Medium
Report
Bluejay Diagnostics (BJDX) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
3/12
06:53 am
bjdx
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting [Yahoo! Finance]
Medium
Report
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting [Yahoo! Finance]
3/12
06:30 am
bjdx
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Medium
Report
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
3/11
09:33 am
bjdx
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics [Yahoo! Finance]
Low
Report
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics [Yahoo! Finance]
3/6
06:30 am
bjdx
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
Low
Report
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
2/20
06:30 am
bjdx
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
Medium
Report
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
2/17
06:30 am
bjdx
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
Medium
Report
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
1/27
08:26 am
bjdx
Bluejay Diagnostics announces 1-for-4 reverse stock split [Seeking Alpha]
High
Report
Bluejay Diagnostics announces 1-for-4 reverse stock split [Seeking Alpha]
1/27
08:00 am
bjdx
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
High
Report
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split